跳至主要内容
临床试验/ISRCTN18128385
ISRCTN18128385已完成不适用

The efficacy of 4 weeks supplementation with Bifidobacterium animalis subsp. lactis, BB-12® in a capsule on overall gastrointestinal well-being, stool frequency and gastrointestinal discomfort symptoms in healthy men and women with abdominal discomfort – a randomized, double-blind, placebo-controlled, parallel group study

Chr. Hansen A/S0 个研究点目标入组 1,740 人开始时间: 2015年2月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,740

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Healthy
  • 2. Age 18–70 years
  • 3. Body-mass index 19–35 kg/m2
  • 4. General abdominal discomfort or complaints
  • 5. A low defecation frequency

排除标准

  • 1. History of hypersensitivity to any of the ingredients of the study products
  • 2. History of lactose intolerance
  • 3. History or diagnosis of gastrointestinal disease, irritable bowel syndrome or complicated gastrointestinal surgery
  • 4. Depressive disorder
  • 5. Any physical abnormality or medical condition that could have an effect on gastrointestinal discomfort
  • 6. Participation in any other clinical study
  • 7. Not willing or able to provide written informed consent for participation in the study or for transmission of personal pseudonymised data
  • 8. Women not willing or able to use a reliable contraceptive method
  • 9. Pregnancy
  • 10. Lactation
  • 11. Wish to become pregnant

研究者

相似试验